Advertisement Martek signs supply agreement with IlDong Foodis - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Martek signs supply agreement with IlDong Foodis

Martek Biosciences Corporation has entered into a multi-year DHA and ARA license and supply agreement for infant formula with IlDong Foodis, an affiliated company of IlDong Pharmaceutical. Accordingly, Martek will serve as the exclusive ARA supplier for all IlDong infant formula products in South Korea.

Martek manufactures nutritional oils that contain the long-chain polyunsaturated fatty acids docosahexaenoic acid (DHA) and arachidonic acid (ARA), both of which are naturally present in breast milk. Clinical studies have demonstrated benefits for infants receiving formula supplemented with DHA and ARA.

Brian Sparg, vice president of global nutrition for Martek, said: “This new agreement is another important step in Martek’s effort to expand its international presence in the infant formula market. Our partnership with IlDong Foodis further demonstrates that companies worldwide understand the importance of adding Martek’s DHA and ARA to infant formula for infant health and development.”